HOME > News > Photo News

Photo News

Provincial Party Committee Secretary and Director of Provincial Standing Committee of NPC Li Hongzhong Meets with Novartis Executives in Switzerland

Release time: 2011-12-15 12:34:35                                      Source: OVC


On December 6, Provincial Party Committee Secretary and Director of Provincial Standing Committee of the NPC Li Hongzhong meets with a member of Novartis Board of Directors Andreas Von Planta and Novartis Global Affairs Director Kim Stratton and other senior executors in Switzerland.


Mr. Andreas Von Planta introduces the R&D and production situations of Novartis, as well as the long-term planning of serving the world’s doctors and patients and promoting the health and treatment development. Li Hongzhong affirms the contribution made by Novartis for the cause of global health, and details the development advantages of biotechnology industry in Hubei Province and Wuhan. Hubei welcomes Novartis and other large multinational companies with strength and credibility to invest. He suggests that Novartis should set up China’s headquarter and R&D and production base in Biolake of Optics Valley of China in Wuhan. Hubei Provincial Party Committee and provincial government will provide first-class services to help Novartis become bigger and stronger. Novartis executives state that they are very optimistic about the broad market and development prospects of Hubei, and they will further intensify its efforts to strengthen exchanges and cooperation with Wuhan East Lake High-tech Development Zone.


Member of Municipal Standing Committee and Secretary of East Lake High-tech Development Zone Party Working Committee Jia Yaobin introduces the talent, cost, and industrial base advantages of Biolake of Optics Valley.


Currently, Biolake of Optics Valley establishes a good relationship with Novartis China. Novartis is a global pharmaceutical and health industry multinational corporation headquartered in Basel, Switzerland. Its operations cover over 140 countries and regions around the world, leading in the global pharmaceutical industry. As one of the world’s largest medical nutrition providers, Novartis ranked No. 168 among Fortune 500 companies in 2007.